Literature DB >> 4472103

Essential thrombocythaemia and peripheral gangrene.

F E Preston, I G Emmanuel, D A Winfield, R G Malia.   

Abstract

Six patients are described in whom gangrene of one or more toes occurred as the presenting feature of essential thrombocythaemia. Spontaneous platelet aggregation was observed in platelet-rich plasma from four patients and platelet aggregation after the addition of adenosine diphosphate and collagen was highly abnormal in samples from all six. All of the patients described dramatic relief of pain within six hours of ingestion of aspirin and this coincided with disappearance of the spontaneous platelet aggregation and collagen-induced platelet aggregation. Treatment with phosphorus-32 corrected the platelet count and there were no further recurrences of peripheral vascular disease. Platelet function tests performed at the time all gave normal results. It is concluded that essential thrombocythaemia is an important and treatable cause of peripheral vascular disease.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4472103      PMCID: PMC1611559          DOI: 10.1136/bmj.3.5930.548

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  Haemorrhagic thrombocythaemia and its treatment with radioactive phosphorus.

Authors:  J R FOUNTAIN; M S LOSOWSKY
Journal:  Q J Med       Date:  1962-04

2.  Hemorrhagic thrombocythemia: a critical review.

Authors:  F W GUNZ
Journal:  Blood       Date:  1960-05       Impact factor: 22.113

3.  Haemorrhagic thrombocythaemia: a clinical and laboratory study.

Authors:  R M HARDISTY; H H WOLFF
Journal:  Br J Haematol       Date:  1955-10       Impact factor: 6.998

4.  Aspirin and recurrent painful toes and fingers in thrombocythaemia.

Authors:  R Biermé; B Boneu; B Guiraud; J Pris
Journal:  Lancet       Date:  1972-02-19       Impact factor: 79.321

5.  The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo.

Authors:  C Thomson; C D Forbes; C R Prentice
Journal:  Clin Sci Mol Med       Date:  1973-10

6.  Inhibition by aspirin of release of antiheparin activity from human platelets.

Authors:  A H Youssef; P Barkhan
Journal:  Br Med J       Date:  1969-08-16
  6 in total
  17 in total

1.  Symmetrical peripheral gangrene.

Authors:  R C McGouran; G A Emmerson
Journal:  Br Heart J       Date:  1977-05

2.  Antiplatelet agents in the treatment of thrombotic complications of primary thrombocythemia.

Authors:  J C Vera
Journal:  Can Med Assoc J       Date:  1979-01-06       Impact factor: 8.262

3.  Superior sagittal sinus thrombosis and essential thrombocythaemia.

Authors:  M F Murphy; C R Clarke; R L Brearley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-05

4.  Non-surgical management of peripheral vascular disease.

Authors:  W Morris-Jones; F E Preston
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-24

5.  Spontaneous platelet aggregation reversed by flurbiprofen.

Authors:  C Politis-Tsegos; S Wolff; S Shaw; T R Mitchell
Journal:  Br Med J       Date:  1978-05-20

Review 6.  The prostanoids in hemostasis and thrombosis: a review.

Authors:  J B Smith
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

7.  Thrombocytosis in rheumatoid arthritis. Recurrent arterial thromboembolism and death.

Authors:  M Ehrenfeld; S Penchas; M Eliakim
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

8.  Thrombocythemia and thrombosis of the adrenal vessels.

Authors:  B Barillari; B Shapiro; D Gasparini; M Rocco; A Barillari; S Buzzolo; E Moratti
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

Review 9.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

10.  [Clinical characterization of essential thrombocythemia in comparison with other myeloproliferative diseases and reactive thrombocytoses].

Authors:  M Jahn; B Zönnchen; W Köpcke; R Hehlmann
Journal:  Klin Wochenschr       Date:  1988-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.